Accuray Incorporated - Common Stock (ARAY)

Paris, France – October 2, 2025 – Nanobiotix (NASDAQ: NBTX) witnessed a significant surge in its stock price today, jumping 11.6%, following the announcement of highly encouraging initial data from a Phase 1 study of its lead product, JNJ-1900 (NBTXR3), in patients with locally advanced esophageal adenocarcinoma. This pivotal development, revealed

Accuray Inc (ARAY) reported mixed Q4 2025 results, beating revenue estimates but missing EPS forecasts. Shares fell 6% post-earnings amid investor concerns over profitability. The company highlighted service growth and completed debt refinancing.

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Russell 2000 ETF (ARCA: IWM) up 2.7%, its strongest session in a month, driven by positive economic data & increased consumer spending, boosting confidence in US economy.

Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news today!

ARAY stock results show that Accuray met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024.

With penny stocks, always do your due diligence before buying. And know upfront that you can lose a lot of money.

Millionaire-maker penny stocks do carry a good deal of risk. But here are a few where insiders are putting their money where their mouth is.